Abstract:SUMMARY During a meningococcal (group A) epidemic, 47 Nigerian children with acute meningococcaemia without meningitis were studied. Their mortality rate was 43 % compared with 8 % during the whole epidemic. Those presenting with coma and shock had a mortality of 93 %, but without shock or coma mortality was only 6%. Coma or shock occurring alone carried an intermediate prognosis. The outcome correlated with initial serum antigen titre, but not with the serum levels of endotoxin, cortisol, or fibrin degradati… Show more
“…As estimated from 24 patients who died in the ICU of the Nijmegen University Hospital (Fig. 2) and data reported in the literature (66, 133,290,299,307,309,333), one-third of the patients with fatal disease die within 6 h after hospital admission and one-third die between 6 and 18 h. Death at a later stage is still determined by the course in the early hours, as shown by the fact that the principal cause of death after 24 h is withdrawal of treatment because of poor neurological prognosis after prolonged cerebral hypoperfusion in the early hours (313).…”
Section: Outcome Of Fulminant Meningococcal Sepsismentioning
confidence: 78%
“…Although preterminal cortisol levels do not correlate with mortality (290,548), individual patients may indeed suffer from adrenal insufficiency (43,205,354,522). A Synacthen test performed on day 3 in patients with extensive DIC and shock at the ICU of the Nijmegen University Hospital revealed adrenal insufficiency in 3 of the 23 patients (cortisol increase, Ͻ0.10 mol/liter after 250 g of Synacthen) and an insufficient response in 4 other patients (cortisol increase, Ͻ0.20 mol/liter).…”
“…As estimated from 24 patients who died in the ICU of the Nijmegen University Hospital (Fig. 2) and data reported in the literature (66, 133,290,299,307,309,333), one-third of the patients with fatal disease die within 6 h after hospital admission and one-third die between 6 and 18 h. Death at a later stage is still determined by the course in the early hours, as shown by the fact that the principal cause of death after 24 h is withdrawal of treatment because of poor neurological prognosis after prolonged cerebral hypoperfusion in the early hours (313).…”
Section: Outcome Of Fulminant Meningococcal Sepsismentioning
confidence: 78%
“…Although preterminal cortisol levels do not correlate with mortality (290,548), individual patients may indeed suffer from adrenal insufficiency (43,205,354,522). A Synacthen test performed on day 3 in patients with extensive DIC and shock at the ICU of the Nijmegen University Hospital revealed adrenal insufficiency in 3 of the 23 patients (cortisol increase, Ͻ0.10 mol/liter after 250 g of Synacthen) and an insufficient response in 4 other patients (cortisol increase, Ͻ0.20 mol/liter).…”
“…Mortality on our ICU during the study period (n = 118) for group O was 0/9 (0%), for group A 5/45 (11%), for group B 3/22 (14%) and for group C 17/42 (40%). As 60 % of the patients in shock who die, succumb within 16 h after admission (data obtained from the 21 fatalities on our ICU plus 95 reported fatalities) [3,7,13,[28][29][30][31][32], patients at risk should be recognized as early as possible.…”
As platelets drop after admission, the use of the platelet count at admission for the assessment of the prognosis in acute meningococcal disease may be misleading. Frequently repeated platelet counts are a better tool for evaluating the severity of disease.
“…Nine other prognostic scoring systems were compared with GMSPS, using the first cohort [4,6,15,17,21,29,34,35,42]. One of the scores [17] was designed for shocked patients and was only evaluated in the subgroup with septic shock.…”
the Glasgow Meningococcal Septicaemia Prognostic Score is an easily performed, repeatable, clinical score that can rapidly identify children with fulminant meningococcal disease. When performed prospectively, a score > or =8 had a positive predictive value for death of 29%. This score can identify those children who should be offered intensive care and can select those who may benefit from novel therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.